1. ‘Too high’ is not a universal peptide number
There is no MO-LAB percentage that makes every stack legal. A 3% of a 10% solution is not a 3% of a powder. Walk the documented peptide aisle as a set of files, not as a single ‘peptide %’ cell. If the brief only has a marketing total, you do not yet have a load. You have a slogan.
2. Column one: what physical form arrived
Powder, pre-dissolved water, glycol concentrate, and a buffered trade blend are four different passengers. A SNAP-8 concentrate writes its solvent into your water the moment you pour it. A dry powder writes a reconstitution step you must own. Put form, INCI, and recommended stage on the same row. Do not merge rows because the brochure used the word peptide twice.
What buyers say
Buyer experience with this exact Mylo-Opt product. Educational content stays primary — this is not scientific proof.
Open the exact product page — Niacinamide 1 kgFor me, niacinamide, nicotinamide, or methyl nicotinate — 2% on the face would be clinically a lot. I dumped it on once and stayed red for a few hours. My skin isn't thin, and it isn't that sensitive or reactive. I use 0.5% and that's fine, no need for more. After a while with niacinamide and nicotinamide the skin kind of gets used to it and barely flushes. Methyl nicotinate is like the first time, every time :)
3. Column two: solids versus the solution you weighed
Write both numbers or write ‘unknown.’ Unknown is a stop. Niacinamide powder is a true solid with its own solubility and pH habit; NAG is another solid if it is on the brief. Do not add those masses to a peptide solution mass and call the sum ‘actives.’ The assay page already killed INCI-as-dose. This column kills spreadsheet-as-dose.
4. Column three: overlapping pH windows — or not
Each row gets the pH language from its own TDS, not from a blog ladder. If two windows do not overlap, you do not have a one-pot. You have two SKUs or a sequenced process you can defend. Measure the chassis after each high-impact row, not once at the end.
5. Column four: solvent and electrolyte tax
Glycols, buffers and counter-ions are why a ‘simple’ serum dies after the third concentrate. Name the tax per row. Then ask whether the gel formers on the brief were chosen for that tax. This is not the published page about viscosity collapse after the fact. This is the refusal to start the batch until the tax is written.
6. Columns five and six: polymer tolerance and preservative
A polymer that stood in purified water is not the polymer that will stand after every row. A preservative chosen on a blank gel is not the preservative after peptide nutrients arrive. Cosgard preservative is a documented complete-system example, not a mandate. Write the system, its pH window, and whether the finished mass will be challenged as that mass — not as the blank.
7. Order, temperature, and the tests you will actually run
Addition order and maximum temperature come from the strictest row, not from habit. Then write the finished-product checks: appearance versus retain, pH, viscosity or pickup, and any identity method you already use on a single lot — repeated on the stack. Read a note on stacking several peptide concentrates as a storefront fact source only. Do not copy its outline. If a cell is empty, the batch is not late. The matrix is incomplete.